INCYTE CORP
INCY · NASDAQ
Updated at 2026-10-14 08:14:04
- Today's High
- $111.67
- Today’s Low
- $107.78
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $114.05
- Previous Close
- $111.36
- Volume
- 1.47M
- Market Cap
- $22.57B
- P/E Ratio
- 14.14X
- EPS
- $7.84
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, UNITED STATES, 19803
- Country
- US
- Listing Date
- 1993-12-06
- Fiscal Year End
- December
- Shares Outstanding
- 202.7M
- CIK
- 0000879169
- Website
- www.incyte.com
Incyte Corp is an American pharmaceutical company based in Alapocas, Delaware.
Financial Metrics
Revenue
2026-06-30
$1.67B
2026-03-31
$1.27B
2025-12-31
$1.5B
2025-09-30
$1.36B
Operating Expenses
2026-06-30
$871.18M
2026-03-31
$844M
2025-12-31
$1B
2025-09-30
$835.68M
Net Income
2026-06-30
$585.6M
2026-03-31
$303.33M
2025-12-31
$299.27M
2025-09-30
$424.16M
Net Profit Margin
2026-06-30
34.98%
2026-03-31
23.83%
2025-12-31
19.86%
2025-09-30
31.05%
Earnings Per Share
2026-06-30
$2.80
2026-03-31
$1.81
2025-12-31
$1.80
2025-09-30
$2.26
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$778.57M
2026-03-31
$367.97M
2025-12-31
$414.5M
2025-09-30
$506.92M
Effective Tax Rate
2026-06-30
22.07%
2026-03-31
11.72%
2025-12-31
23.25%
2025-09-30
12.05%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $1.67B | $1.27B | $1.5B | $1.36B |
| Operating Expenses | $871.18M | $844M | $1B | $835.68M |
| Net Income | $585.6M | $303.33M | $299.27M | $424.16M |
| Net Profit Margin | 34.98% | 23.83% | 19.86% | 31.05% |
| Earnings Per Share | $2.80 | $1.81 | $1.80 | $2.26 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $778.57M | $367.97M | $414.5M | $506.92M |
| Effective Tax Rate | 22.07% | 11.72% | 23.25% | 12.05% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.